Literature DB >> 15063124

An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.

Ilona Reimann1, Klaus Depner, Sascha Trapp, Martin Beer.   

Abstract

A chimeric Pestivirus was constructed using an infectious cDNA clone of bovine viral diarrhea virus (BVDV) [J. Virol. 70 (1996) 8606]. After deletion of the envelope protein E2-encoding region, the respective sequence of classical swine fever virus (CSFV) strain Alfort 187 was inserted in-frame resulting in plasmid pA/CP7_E2alf. After transfection of in vitro-transcribed CP7_E2alf RNA, autonomous replication of chimeric RNA in bovine and porcine cell cultures was observed. Efficient growth of chimeric CP7_E2alf virus, however, could only be demonstrated on porcine cells, and in contrast to the parental BVDV strain CP7, CP7_E2alf only inefficiently infected and propagated in bovine cells. The virulence, immunogenicity, and "marker vaccine" properties of the generated chimeric CP7_E2alf virus were determined in an animal experiment using 27 pigs. After intramuscular inoculation of 1 x 10(7) TCID(50), CP7_E2alf proved to be completely avirulent, and neither viremia nor virus transmission to contact animals was observed; however, CSFV-specific neutralizing antibodies were detected from day 11 after inoculation. In addition, sera from all animals reacted positive in an E2-specific CSFV-antibody ELISA, but were negative for CSFV-E(RNS)-specific antibodies as determined with a CSFV marker ELISA. After challenge infection with highly virulent CSFV strain Eystrup, pigs immunized with CP7_E2alf were fully protected against clinical signs of CSFV infection, viremia, and shedding of challenge virus, and almost all animals scored positive in a CSFV marker ELISA. From our results, we conclude that chimeric CP7_E2alf may not only serve as a tool for a better understanding of Pestivirus attachment, entry, and assembly, but also represents an innocuous and efficacious modified live CSFV "marker vaccine".

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063124     DOI: 10.1016/j.virol.2004.01.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Thioredoxin 2 Is a Novel E2-Interacting Protein That Inhibits the Replication of Classical Swine Fever Virus.

Authors:  Su Li; Jinghan Wang; Wen-Rui He; Shuo Feng; Yongfeng Li; Xiao Wang; Yajin Liao; Hua-Yang Qin; Lian-Feng Li; Hong Dong; Yuan Sun; Yuzi Luo; Hua-Ji Qiu
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

2.  Co-expression of the C-terminal domain of Yersinia enterocolitica invasin enhances the efficacy of classical swine-fever-vectored vaccine based on human adenovirus.

Authors:  Helin Li; Pengbo Ning; Zhi Lin; Wulong Liang; Kai Kang; Lei He; Yanming Zhang
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

3.  Autonomously Replicating RNAs of Bungowannah Pestivirus: ERNS Is Not Essential for the Generation of Infectious Particles.

Authors:  Anja Dalmann; Ilona Reimann; Kerstin Wernike; Martin Beer
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

4.  Differentiation of classical swine fever virus infection from CP7_E2alf marker vaccination by a multiplex microsphere immunoassay.

Authors:  Hongyan Xia; Rajiv Harimoorthy; Balaje Vijayaraghavan; Sandra Blome; Frederik Widén; Martin Beer; Sándor Belák; Lihong Liu
Journal:  Clin Vaccine Immunol       Date:  2014-11-05

5.  Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis.

Authors:  Steve Lecot; Sandrine Belouzard; Jean Dubuisson; Yves Rouillé
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Assessment of the control measures of the category A diseases of Animal Health Law: Classical Swine Fever.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Liisa Helena Sihvonen; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Simon Gubbins; Jan Arend Stegeman; Sotiria-Eleni Antoniou; Inma Aznar; Alessandro Broglia; Eliana Lima; Yves Van der Stede; Gabriele Zancanaro; Helen Clare Roberts
Journal:  EFSA J       Date:  2021-07-21

7.  Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China.

Authors:  Ning Chen; Chao Tong; Dejiang Li; Jing Wan; Xuemei Yuan; Xiaoliang Li; Jinrong Peng; Weihuan Fang
Journal:  Virol J       Date:  2010-12-31       Impact factor: 4.099

Review 8.  Structures and Functions of Pestivirus Glycoproteins: Not Simply Surface Matters.

Authors:  Fun-In Wang; Ming-Chung Deng; Yu-Liang Huang; Chia-Yi Chang
Journal:  Viruses       Date:  2015-06-29       Impact factor: 5.048

9.  Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever.

Authors:  Tinka Jelsma; Jacob Post; Erwin van den Born; Ruud Segers; Jeroen Kortekaas
Journal:  Vaccines (Basel)       Date:  2021-05-10

10.  CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.

Authors:  Patricia Renson; Mireille Le Dimna; André Keranflech; Roland Cariolet; Frank Koenen; Marie-Frédérique Le Potier
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.